Newron Pharmaceuticals S.p.A. (SWX:NWRN)
16.50
-1.00 (-5.71%)
At close: Mar 12, 2026
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
2.54M CHF
Profits / Employee
1.08M CHF
Market Cap
363.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 22 | 0 | - |
| Dec 31, 2023 | 22 | -1 | -4.35% |
| Dec 31, 2022 | 23 | -2 | -8.00% |
| Dec 31, 2021 | 25 | 2 | 8.70% |
| Dec 31, 2020 | 23 | -3 | -11.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Basilea Pharmaceutica AG | 189 |
| Molecular Partners AG | 153 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 29 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |